HVTN 105 Study: Monitoring HIV-Specific Antibody and T-Cell Responses

HVTN 105 Study: Monitoring HIV-Specific Antibody and T-Cell Responses

Randomized DNA and protein vaccines were administered in four randomized treatment groups to determine which strategy would induce favorable HIV-specific antibody and T-cell responses. The study was led by Nadine Rouphael, MD, protocol co-chair and Investigator at the...

Pin It on Pinterest